J Korean Med Assoc.  2012 Dec;55(12):1161-1162. 10.5124/jkma.2012.55.12.1161.

On the life-sustaining treatment in Korea

• Lee YS

• KMID: 2015659
• DOI: http://doi.org/10.5124/jkma.2012.55.12.1161

Abstract

No abstract available.

MeSH Terms

Korea

Reference

1. Korean Medical Association. Korean Academy of Medical Sciences. Korean Hospital Association. Guideline to withdrawal of a life-sustaining therapy. 2009. Seoul: Korean Medical Association.

2. Heo DS. Patient autonomy and advance directives in Korea. J Korean Med Assoc. 2009. 52:865–870.

3. Bae JM, Gong JY, Lee JR, Heo DS, Koh Y. A survey of patients who were admitted for life-sustaining therapy in nationwide medical institutions. Korean J Crit Care Med. 2010. 25:16–20.

4. Koh Y, Heo DS, Yun YH, Moon JL, Park HW, Choung JT, Jung HS, Byun BJ, Lee YS. Charactersitics and issues of guideline to withdrawal of a life-sustaining therapy. J Korean Med Assoc. 2011. 54:747–757.

5. Hong YS. Past, present and future of hospice in Korea. J Korean Med Assoc. 2008. 51:509–516.

6. Hong YS, Lee KS. Institutionalization of hospice. Korean J Hosp Palliat Care. 2002. 5:81–89.